Proteolix's Series C Round

Proteolix raised a round of funding on September 12, 2008.

Proteolix is a biopharmaceutical company dedicated to discovering, developing and marketing pharmaceutical products that target certain cancers by introducing proteasome inhibition and thereby disrupt…

Articles about Proteolix's Series C Round: